missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Tenascin C Polyclonal Antibody
Description
Positive Control: Target recombinant protein Predicted Reactivity: Mouse (92%), Rat (91%), Dog (95%), Pig (91%), Chicken (84%), Bovine (90%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Tenascin is a high molecular weight, multifunctional, extracellular matrix glycoprotein expressed in association with mesenchymal-epithelial interactions during development and in the neovasculature and stroma of undifferentiated tumors (Erickson and Bourdon 1989). It has been described under a variety of names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymal extracellular matrix (GMEM). The tenascin molecule is a disulfide-linked hexamer. The expression of tenascin is associated with development and growth, both normal and pathological, whereas the distribution in normal adult tissue is restricted.
Specifications
Specifications
| Antigen | Tenascin C |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | TNC |
| Gene Accession No. | P24821 |
| Gene Alias | 150-225; AI528729; C130033P17Rik; cytotactin; deafness, autosomal dominant 56; DFNA56; Glioma-associated-extracellular matrix antigen; GMEM; GP; GP 150-225; hexabrachion; hexabrachion (tenascin); Hxb; JI; MGC144208; MGC144209; MGC167029; Myotendinous antigen; neuronectin; Ten; Tenascin; tenascin C; Tenascin-C; tenascin-C additional domain 1; tenascin-C isoform 14/AD1/16; TN; tnc; TN-C |
| Gene Symbols | TNC |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?